22.418 articles found

Future directions in the treatment of Parkinson's disease.

Schapira AH.

Mov Disord · 2007-09-01

DOI: 10.1002/mds.21679PMID: 18175401

Proceedings of the 10th International Symposium on the Treatment of Parkinson's Disease, Kobe, Japan, 2005.

Check source for author details

Mov Disord · 2007-09-01

PMID: 18286708

The pharmacokinetics and pharmacodynamics of levodopa in the treatment of Parkinson's disease.

Khor SP, Hsu A.

Curr Clin Pharmacol · 2007-09-01

DOI: 10.2174/157488407781668802PMID: 18690870

Design of clinical trials of gene therapy in Parkinson disease.

Lewis TB, Standaert DG.

Exp Neurol · 2007-08-31

DOI: 10.1016/j.expneurol.2007.08.012PMID: 17920590

USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE.

DOE JOHN ERNEST, STURGESS NICHOLAS CRISPINIAN, TRAVIS KIM ZACHARY.

· 2007-08-27

Current status of gene therapy trials for Parkinson's disease.

Fiandaca M, Forsayeth J, Bankiewicz K.

Exp Neurol · 2007-08-24

DOI: 10.1016/j.expneurol.2007.08.009PMID: 17920059

A regulatory perspective on the development of gene therapy for Parkinson's disease.

Havert MB.

Exp Neurol · 2007-08-24

DOI: 10.1016/j.expneurol.2007.08.010PMID: 17949714

The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease.

Zhang S, Zou Z, Jiang X, Xu R, Zhang W, Zhou Y, Ke Y.

Cell Mol Neurobiol · 2007-08-23

DOI: 10.1007/s10571-007-9191-8PMID: 17713852

Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?

Kordower JH, Olanow CW.

Exp Neurol · 2007-08-22

DOI: 10.1016/j.expneurol.2007.08.001PMID: 17888424

Preclinical development of gene therapy for Parkinson's disease.

Porras G, Bezard E.

Exp Neurol · 2007-08-22

DOI: 10.1016/j.expneurol.2007.08.003PMID: 17904121

An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease.

Epstein CM, Evatt ML, Funk A, Girard-Siqueira L, Lupei N, Slaughter L, Athar S, Green J, McDonald W, DeLong MR.

Clin Neurophysiol · 2007-08-21

DOI: 10.1016/j.clinph.2007.07.010PMID: 17714987

rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.

Cardoso EF, Fregni F, Martins Maia F, Boggio PS, Luis Myczkowski M, Coracini K, Lopes Vieira A, Melo LM, Sato JR, Antonio Marcolin M, Rigonatti SP, Cruz AC, Reis Barbosa E, Amaro E.

Int J Neuropsychopharmacol · 2007-08-21

DOI: 10.1017/s1461145707007961PMID: 17708780